Effects of GnRH agonist for luteal support on improvement of IVF/ICSI cycles
Phase 2
- Conditions
- Complication associated with artificial fertilization, unspecifiedoninflammatory disorders of female genital tract.
- Registration Number
- IRCT20160722029027N6
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 240
Inclusion Criteria
Age between 20-38 years old
Body mass index (BMI) between 20-30
Fresh embryo transfer cycles
3rd menstrual day serum FSH below 10
Absence of low ovarian response according Bologna Criteria
Exclusion Criteria
Unwillingness to continue
Absence of good quality embryo
Ovarian hyper stimulation (more than 18 mature follicle during ovarian stimulation)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: Serum BHCG.
- Secondary Outcome Measures
Name Time Method Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Fetal heart beat in ultrasound.;Abortion. Timepoint: Before 20 weeks of pregnancy. Method of measurement: Fetal demise before 20 weeks of gestation.